Geneos Wealth Management’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-94
Closed -$1K 1997
2022
Q2
$1K Hold
94
﹤0.01% 2453
2022
Q1
$3K Sell
94
-32
-25% -$1.35K ﹤0.01% 2443
2021
Q4
$6K Sell
126
-867
-87% -$58.3K ﹤0.01% 2330
2021
Q3
$70K Sell
993
-1
-0.1% -$71 ﹤0.01% 1325
2021
Q2
$85K Sell
994
-84
-8% -$7.28K ﹤0.01% 1225
2021
Q1
$95K Sell
1,078
-6
-0.6% -$671 ﹤0.01% 1331
2020
Q4
$97K Buy
1,084
+816
+304% +$59.5K ﹤0.01% 1157
2020
Q3
$13K Sell
268
-22
-8% -$2.09K ﹤0.01% 1849
2020
Q2
$36K Buy
+290
New +$33K ﹤0.01% 1361

Other funds holding ACB

Geneos Wealth Management's ACB Position: Q3 2022 in Review

Geneos Wealth Management sold out of Aurora Cannabis (ACB) in Q3 2022, closing a stake of 94 shares — an estimated $1K sold.

Geneos Wealth Management first reported a position in ACB in Q2 2020 and held it in 9 quarters. The position peaked at $97K in Q4 2020. 238 funds tracked by Wall St. Rank hold ACB as of Q3 2022.

  • Geneos Wealth Management reported no remaining Aurora Cannabis position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 94 Aurora Cannabis shares in Q3 2022, an estimated $1K.
  • Geneos Wealth Management first reported a position in Aurora Cannabis in Q2 2020 and held it in 9 quarters.
  • Geneos Wealth Management's Aurora Cannabis position peaked at $97K in Q4 2020.
  • 238 funds tracked by Wall St. Rank held Aurora Cannabis as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.